InvestorsHub Logo
Followers 17
Posts 1891
Boards Moderated 0
Alias Born 01/29/2020

Re: whatdoyouseek post# 148510

Thursday, 09/10/2020 6:42:41 AM

Thursday, September 10, 2020 6:42:41 AM

Post# of 194941
Now you’re thinking and starting to understand the cost for software development. But the subscription SaaS (software as a service) model has unlimited Rev capability, because the consumer never owns the software. They just pay for the subscription like cable TV. If telepharm becomes the new normal like telemedicine has become with COVID-19 then RXMD will be off to the races. Honestly I think it will. Who wants to go the pharmacy, stand in line, and wait for their meds even before C-19? There’s no value added in this model. Information Technology (IT) removes no value added tasks to make life more efficient! As telepharm becomes the new norm we will be set owning a IT company. CallingDr will be one additional revenue stream for RXMD, but the new web app they will be focused on launching will be called something like CallingRx! It will allow patients to interact with the pharmacy via app and meds will be delivered to the door. Docs will interact with the app too. No longer need to waste time on the phone or pay someone to call in scripts. Many of you don’t understand the value of IT and have a narrow vision! Wake up and buy RXMD while the price in low.

$RXMD LONG AND STRONG!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RXMD News